Clinical trial

Citalopram Titration in Early Non-responder Patients With Major Depressive Disorders

NCT03899285

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Citalopram 20mg or 40 mg (phase 2) Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Citalopram Titration in Early Non-responder Patients With Major Depressive Disorders

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2018-01-08

PhasePHASE2

Conditions

Major Depressive Disorderverified · MONDO: major depressive disorder

Interventions

Citalopram 20mg or 40 mg (phase 2)DRUG

Sponsors & collaborators

Ciusss de L'Est de l'Île de Montréallead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03899285 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.